Medipan GmbHhat einen Beitrag geschrieben.19. Januar 2018
Why should radioactive test reagents still be used in diagnostics, as nowadays more and more people disapprove radioactive technology? To put it simple: many areas of modern medicine would not be possible without the use of radioactive treatments, and in the field of diagnostics there are many radioactive test reagents that are still recognized as gold standard methods.
Today the number of companies still offering radioimmunoassay (RIA) reagents is becoming smaller and smaller. We at MEDIPAN a...
Medipan GmbHhat einen Beitrag geschrieben.18. Januar 2018
20 JAHRE RADIOIMMUNOASSAYS FÜR DIE DIABETESDIAGNOSTIK!
Zu Anfang des Jahres 2018 haben einige Wettbewerber ihre Radioimmunoassays für die Diabetesdiagnostik (anti-GAD, anti-IA2) eingestellt. Wir freuen uns mitteilen zu können dass die Firma Medipan diese Produkte weiterhin anbietet. Seit 20 Jahren steht unsere Produktlinie CentAK für effiziente Testsysteme zum Nachweis von Autoantikörpern gegen GAD65,IA2 & Insulin
Medipan GmbHhat einen Beitrag geschrieben.18. Oktober 2017
Medipan's Cytobead® Technology: Screening and Confirmation combined
The AKLIDES® CytoBead® ANCA, ANA, ANA 2, CeliAK and RPGN test kits are designed for the diagnosis of systemic and organ specific autoimmune disease, via indirect immunofluorescence.
The AKLIDES® CytoBead® ANCA, ANA, ANA 2, CeliAK and RPGN test kits consist of reagents to determine IgG autoantibodies against neutrophil cytoplasmic antigens (CytoBead® ANCA and CytoBead® RPGN), nuclear and cytoplasmic antigens (CytoBead® ANA a...
Medipan GmbHhat einen Beitrag geschrieben.18. Oktober 2017
International Trade Fair with Forums and Conferences
Medica - World Forum for Medicine | 13 - 16 November 2017
Venue: Exhibition Centre and Congress Center, Düsseldorf, Germany
visit us @ Hall 3/G60
